Shattuck Labs, Inc. (STTK) vs Zevra Therapeutics, Inc. (ZVRA)

Shattuck Labs, Inc. and Zevra Therapeutics, Inc. are both Biotechnology companies. Shattuck Labs, Inc. and Zevra Therapeutics, Inc. are of similar size ($668.7M and $633.3M). Shattuck Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 11.6×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 119.4% against 106.5%. Zevra Therapeutics, Inc. has the higher net margin (42.3% vs 0.00%) and the higher return on invested capital (0.00% vs −1,230.7%). Across the 17 metrics below, Zevra Therapeutics, Inc. leads on 14 and Shattuck Labs, Inc. on 3.

Valuation

Metric STTK ZVRA Biotechnology median
P/E n/m 11.62 7.88
P/S 140.52 4.80 11.47
P/B 3.73 3.00 2.52
Price to free cash flow n/m 19.75 21.16
EV/EBITDA n/m 6.59 0.74
EV/Sales 103.36 3.90 10.73
Earnings yield (8.40%) 8.61% (28.84%)
Free cash flow yield (5.24%) 5.06% (23.03%)

Profitability

Metric STTK ZVRA Biotechnology median
Gross margin 100.00% 95.46% 65.16%
Operating margin 0.00% 60.54% 0.00%
Net margin 0.00% 42.25% 0.00%
Free cash flow margin 0.00% 24.30% 0.00%
Return on equity (39.21%) 34.33% (57.72%)
Return on assets (36.88%) 20.57% (49.22%)
Return on invested capital (1,230.74%) 0.00% 0.00%

Growth

Metric STTK ZVRA Biotechnology median
Revenue growth (TTM) 106.48% 119.40% 5.64%
EPS growth (last fiscal year) 53.02% 159.21% —
Revenue growth, 5-year CAGR (36.82%) 51.62% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric STTK ZVRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 27.59 5.17 4.73
Net debt to EBITDA 1.62 39.03 0.96

Dividend

Metric STTK ZVRA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric STTK ZVRA Biotechnology median
Market cap 633.29m 668.66m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack